Evidence-based Clinical Practice Guidelines for the Follow-Up of At-Risk Neonates. Abriged version
MetadataShow full item record
Other Language Versions
In this abridged version of the Evidence-based Clinical Practice Guidelines for the Follow-Up of at-risk neonates, we provide recommendations for the care of newborns up to 2 years of age, corresponding to the first phase of their follow-up. The recommendations are intended for all health sector staff responsible for the primary care of these neonates: general practitioners, family practitioners, pediatricians, neonatologists, pediatric ophthalmologists, pediatric otolaryngologists, nursing professionals, specialists in other fields, and multidisciplinary staff involved in the care process. The purpose of these guidelines is to facilitate policy implementation processes carried out by decision-makers and members of government bodies, and will also be useful for parents, mothers, and caregivers. The main topics covered by this document include the hospital discharge criteria, including screening tests; information and support for parents, mothers, and caregivers; screening at the follow-up visit, and the frequency of follow-ups until the infant is 2 years of age. These guidelines do not address matters related to nursing or comorbidities.
Evidence-based Clinical Practice Guidelines for the Follow-Up of At-Risk Neonates. Abriged version. Washington, D.C.: Pan American Health Organization; 2021. License: CC BY-NC-SA 3.0 IGO.
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO
Showing items related by title, author, creator and subject.
Niermeyer, Susan; Domek, Gretchen (Montevideo, CLAP, 2016-11)Background: Reduction in neonatal mortality is central to achieving global child survival targets in the coming decades. Efforts to prevent the primary causes of neonatal death (prematurity, asphyxia, severe infections, ...
Balcázar, Héctor; Haas, Jere D (1991)The study reported here classified 9,660 newborn infants delivered at a maternal and chid health center in México City by length of gestation, presence or absence of growth retardation, and (in the case of growth-retarded ...
Pan American Health Organization (Washington, D.C., PAHO, 2005)BACKGROUND In many countries neonatal tetanus is responsible for half of all neonatal deaths due to vaccine-preventable diseases and for almost 14% of al¡ infant deaths. It is estimated that in the 1970s more than 10,000 ...